Literature DB >> 8690453

Alloantigen-specific T-cell anergy induced by human keratinocytes is abrogated upon loss of cell-cell contact.

H G Otten1, B Bor, C Ververs, L F Verdonck, M De Boer, G C De Gast.   

Abstract

The activation of primary human T cells largely depends on the expression of both major histocompatibility complex (MHC) class II and B7 molecules on antigen-presenting cells (APC), whereas APC expressing HLA class II but not B7 antigens are expected to induce anergy. According to this concept, interferon-gamma (IFN-gamma)-activated keratinocytes (KC) expressing HLA class II but not B7 costimulatory antigens should be able to induce anergy. However, in terms of anergy versus activation contradicting data have been published on the outcome of interaction between T cells and human KC. In addition, it has been shown that human KC can express a B7-like molecule with unknown function, whereas MHC expression may be functionally impaired. To evaluate this item we transfected the human A431 KC cell line with B7-1 coding sequences and up-regulated HLA-DR by treatment with IFN-gamma, yielding A431DR,B7-1 cells. Irradiated A431DR,B7-1 cells were found to be capable of inducing vigorous proliferative primary T-cell responses in resting allogeneic T cells, whereas A431DR cells could induce proliferation only when interleukin-2 (IL-2) was added. These data indicate that KC can present alloantigens, and that lack of costimulatory molecules on KC is the main reason why these cells cannot induce primary T-cell responses. Surprisingly, however, no evidence could be obtained of stable anergy induction by A431DR cells, as T cells contacted with A431DR cells and then transferred to A431DR,B7-1 cells clearly demonstrated alloresponsiveness. T-cell non-responsiveness was maintained only when T cells remained in contact with A431DR cells. These data indicate that, despite expression of HLA class II in the absence of B7 costimulatory molecules, human KC cannot induce stable anergy but rather induce short-term anergy in primary resting T cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690453      PMCID: PMC1456420          DOI: 10.1111/j.1365-2567.1996.tb00007.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Functional characterization of a novel anti-B7 monoclonal antibody.

Authors:  M de Boer; P Parren; J Dove; F Ossendorp; G van der Horst; J Reeder
Journal:  Eur J Immunol       Date:  1992-12       Impact factor: 5.532

Review 2.  Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy.

Authors:  R H Schwartz
Journal:  Cell       Date:  1992-12-24       Impact factor: 41.582

3.  Keratinocytes produce a lymphocyte inhibitory factor which is partially reversible by an antibody to transforming growth factor-beta.

Authors:  B J Nickoloff
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

4.  Antigen presentation by keratinocytes induces tolerance in human T cells.

Authors:  V Bal; A McIndoe; G Denton; D Hudson; G Lombardi; J Lamb; R Lechler
Journal:  Eur J Immunol       Date:  1990-09       Impact factor: 5.532

5.  A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-02-25       Impact factor: 16.971

6.  An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants.

Authors:  G B Vogelsang; A D Hess; A W Berkman; P J Tutschka; E R Farmer; P J Converse; G W Santos
Journal:  N Engl J Med       Date:  1985-09-12       Impact factor: 91.245

7.  Phorbol-12-myristate-13-acetate-treated human keratinocytes express B7-like molecules that serve a costimulatory role in T-cell activation.

Authors:  M Augustin; A Dietrich; R Niedner; A Kapp; E Schöpf; J A Ledbetter; W Brady; P S Linsley; J C Simon
Journal:  J Invest Dermatol       Date:  1993-03       Impact factor: 8.551

8.  Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction.

Authors:  B J Nickoloff; R S Mitra; J Green; X G Zheng; Y Shimizu; C Thompson; L A Turka
Journal:  J Immunol       Date:  1993-03-15       Impact factor: 5.422

9.  HLA class II+ human keratinocytes present Mycobacterium leprae antigens to CD4+ Th1-like cells.

Authors:  T Mutis; M De Bueger; A Bakker; T H Ottenhoff
Journal:  Scand J Immunol       Date:  1993-01       Impact factor: 3.487

Review 10.  Allorecognition and graft-versus-host disease.

Authors:  M Theobald
Journal:  Bone Marrow Transplant       Date:  1995-04       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.